	2017 Mar 31	2018 Mar 31	2019 Mar 31	C 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2017 Mar 31	2018 Mar 31	2019 Mar 31	C 2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS	12M IR
Total Revenue	1,714	1,695	2,059	2,044	1,912	2,141	2,413	2,616	2,712	2,932	2,901
Cost of Operating Revenue	600	638	754	818	832	847	907	1,035	914	747	773
Gross Profit	1,113	1,057	1,305	1,226	1,080	1,294	1,506	1,581	1,798	2,184	2,129
Gross Margin	65.0	62.4	63.4	60.0	56.5	60.4	62.4	60.4	66.3	74.5	73.4
Total Operating Expenses	1,465	1,444	1,724	1,811	1,929	2,111	2,307	2,624	2,525	2,705	2,764
Operating Profit	249	251	335	232	-17	30	105	-8	187	227	137
Operating Margin	14.5	14.8	16.3	11.4	-0.9	1.4	4.4	-0.3	6.9	7.7	4.7
Financing Income/(Expense) - Net	-36	-51	-63	-54	-40	-37	-118	-116	-161	-174	-169
Profit before Taxes	216	231	309	197	-65	-4	-55	-122	19	105	15
Income Taxes	71	76	98	39	100	-22	-25	31	16	7	-1
Profit after Tax	145	155	210	159	-165	18	-30	-153	3	97	16
PAT Margin	8.5	9.1	10.2	7.8	-8.6	0.8	-1.2	-5.9	0.1	3.3	0.6
EPS - Basic - ex Extraordinary Items	9.01	9.58	13.03	9.85	-10.53	1.15	-1.90	-9.79	0.21	6.22	1.03
EPS - Diluted - ex Extraordinary Items	9.01	9.58	13.03	9.85	-10.53	1.15	-1.90	-9.79	0.21	6.22	1.03
EBIT	249	251	335	232	-17	30	105	-8	187	227	137
EBITDA	462	462	487	515	290	337	386	302	480	566	485
EBITDA Margin	27.0	27.3	23.6	25.2	15.2	15.8	16.0	11.6	17.7	19.3	16.7

Balance Sheet

Abridged

Understanding Balance Sheet

Dishman Carbogen Amcis Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2017 Mar 31	2018 Mar 31	2019 Mar 31	C 2020 Mar 31	R 2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2017 Mar 31	2018 Mar 31	2019 Mar 31	C 2020 Mar 31	R 2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	IR	AR	AR	AR	AR	PRESS
Total Current Assets	1,333	1,546	1,554	1,779	1,704	1,839	1,918	1,928	2,200	284
Long-Term Investments	5	5	5	5	5	5	5	4	4	2
Property Plant & Equipment - Net	1,465	1,622	1,676	2,093	2,441	2,787	3,227	3,232	3,171	344
Total Non-Current Assets	5,260	5,630	5,775	6,421	6,662	6,799	7,535	7,653	7,799	908
Total Assets	6,593	7,176	7,328	8,200	8,366	8,637	9,454	9,581	9,999	1,192
Total Current Liabilities	994	1,178	1,198	1,569	1,290	1,420	1,798	2,555	1,925	232
Long Term Debt	460	525	362	477	869	1,110	1,370	532	1,390	132
Total Non-Current Liabilities	786	891	751	916	1,377	1,669	1,845	1,399	2,216	293
Total Liabilities	1,779	2,069	1,949	2,485	2,667	3,089	3,644	3,954	4,141	525
Total Shareholders' Equity	4,814	5,107	5,379	5,715	5,699	5,549	5,810	5,628	5,858	668
Total Equity	4,814	5,107	5,379	5,715	5,699	5,549	5,810	5,628	5,858	668
Total Liabilities & Equity	6,593	7,176	7,328	8,200	8,366	8,637	9,454	9,581	9,999	1,192

Cash Flow

Abridged

Understanding Cash Flow Statement

Dishman Carbogen Amcis Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	C 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	C 2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	270.98	360.35	406.92	484.21	227.51	232.10	246.00	153.64	307.09	-238.15
Working Capital - Increase/(Decrease)	-7.31	-168.54	-166.80	62.84	273.90	90.08	-37.73	143.83	-80.59	287.29
Net CF from Operating Activities	263.67	191.81	240.12	547.05	501.41	322.18	208.27	297.47	226.50	34.47
Capital Expenditures - Net	138.54	204.66	273.03	408.56	366.03	455.47	618.20	303.12	215.47	26.54
Net CF from Investing Activities	-154.93	-311.36	-184.31	-464.81	-421.62	-645.65	-509.68	-241.65	-194.44	-25.46
Dividends Paid - Cash - Total	-	-	-	3.23	-	-	-	-	-	-
Stock - Issuance/(Retirement) - Net	-	-	-	-36.65	-2.31	-	-	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	-64.91	126.46	-45.03	3.24	44.12	190.16	322.95	76.48	48.87	35.66
Net Cash Flow from Financing Activities	-85.58	126.45	-45.02	-36.63	41.81	190.16	322.95	76.48	48.87	35.66
Free Cash Flow to Equity	60.22	113.61	-77.94	141.73	179.50	56.87	-86.98	70.83	59.90	43.59
Free Operating CF net dividend	115.71	-24.64	-67.99	135.26	135.38	-141.62	-411.41	-5.78	9.74	7.87
Free Operating CF	115.71	-24.64	-67.99	138.49	135.38	-141.62	-411.41	-5.78	9.74	7.87

Business Segment Analysis

FY End:

Mar 25

Dishman Carbogen Amcis Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Contract Research and Manufacturing Services (CRAMS), quats, specialty chemicals, Vitamins D3 (100.0%)₹ 216.76 Cr

Revenue / Sales

Contract Research and Manufacturing Services (CRAMS), quats, specialty chemicals, Vitamins D3 (100.0%)₹ 2,711.50 Cr

Assets

Contract Research and Manufacturing Services (CRAMS), quats, specialty chemicals, Vitamins D3 (100.0%)₹ 9,999.15 Cr

Operating Income

Contract Research and Manufacturing Services (CRAMS), quats, specialty chemicals, Vitamins D3 (100.0%)₹ 186.56 Cr

Regional Segment Analysis

FY End:

Mar 22

Dishman Carbogen Amcis Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

Rest of the World (98.3%)₹ 2,104.03 CrIndia (1.7%)₹ 36.65 Cr

Assets

Rest of the World (74.2%)₹ 6,408.73 CrIndia (25.8%)₹ 2,228.72 Cr

Historical Segment Analysis

Track how Dishman Carbogen Amcis Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2023 Mar 31	2024 Mar 31	2025 Mar 31
	2023 Mar 31	2024 Mar 31	2025 Mar 31
Contract Research and Manufacturing Services (CRAMS), quats, specialty chemicals, Vitamins D3	574	303	217

Frequently Asked Questions

What is the revenue of Dishman Carbogen Amcis Ltd.?

The latest trailing twelve month revenue of Dishman Carbogen Amcis Ltd. is ₹ 1,527.17 Cr, reflecting a 1-year growth of -47.26% and a 3-year CAGR of -16.21%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Dishman Carbogen Amcis Ltd.?

The latest trailing twelve month net profit (PAT) of Dishman Carbogen Amcis Ltd. is ₹ 68.25 Cr. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Dishman Carbogen Amcis Ltd.?

The trailing twelve month EBITDA of Dishman Carbogen Amcis Ltd. is approximately ₹ 166.37 Cr (based on an operating margin of 10.89%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Dishman Carbogen Amcis Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Dishman Carbogen Amcis Ltd. is 6.22. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Dishman Carbogen Amcis Ltd.?

The debt-to-equity ratio of Dishman Carbogen Amcis Ltd. stands at 0.43. The interest coverage ratio is 1.04x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Dishman Carbogen Amcis Ltd.?

The estimated book value per share of Dishman Carbogen Amcis Ltd. is 42.59 (derived from a P/B ratio of 4.12 and market price of ₹ 175.27), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Dishman Carbogen Amcis Ltd.?

The trailing twelve month operating cash flow of Dishman Carbogen Amcis Ltd. is ₹ 34.47 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Dishman Carbogen Amcis Ltd. report consolidated or standalone financials?

Dishman Carbogen Amcis Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.